SCHEMBL19224573

SCHEMBL19224573

CN1C(=O)[C@@H](N)C2CC2c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 5/20 0.43
AADAT Q8N5Z0 1/20 0.42
GLRA3 O75311 1/20 0.39
GLRA1 P23415 1/20 0.39
GLRB P48167 1/20 0.39
EGFR P00533 1/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
HRH1 P35367 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19224579 1.00 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
SCHEMBL19224501 1.00 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
SCHEMBL19228383 1.00 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
SCHEMBL20050169 1.00 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
SCHEMBL19228388 1.00 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
Hydrochloric Acid SCHEMBL30890746 0.98 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
Hydrochloric Acid SCHEMBL22493996 0.98 RIPK1 (0.43) RIPK1AADATGLRA3GLRA1GLRB
SCHEMBL20442407 0.78 GLRA3 (0.46) RIPK1GLRA3GLRA1GLRBEGFR
SCHEMBL19805466 0.77 RIPK1 (0.47) RIPK1HTR2AHTR2CHRH1ADRA2A
SCHEMBL19228469 0.77 RIPK1 (0.47) RIPK1HTR2AHTR2CHRH1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9815850-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2017-11-14 US disclosed
US-9815850-B2 Compounds, compositions and methods DENALI THERAPEUTICS INC. (US) 2017-11-14 US disclosed
US-20170226127-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. 2017-08-10 US disclosed
US-20170226127-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226127-A1 COMPOUNDS, COMPOSITIONS AND METHODS PIK3CA, PLK1, PIK3CB RIPK1 416/4885AADAT 3982/4885GLRA3 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.